ClinicalTrials.gov
ClinicalTrials.gov Menu

Markers and Mechanisms of Macrovascular Disease in IDDM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00005474
Recruitment Status : Completed
First Posted : May 26, 2000
Last Update Posted : April 14, 2015
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Medical University of South Carolina

Brief Summary:
To elucidate the biochemical, metabolic, and genetic markers and mechanisms of macrovascular disease in insulin dependent diabetes mellitus (IDDM).

Condition or disease
Cardiovascular Diseases Diabetes Mellitus Atherosclerosis Heart Diseases Diabetes Mellitus, Insulin-dependent

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 1063 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : September 1996
Actual Primary Completion Date : August 2008
Actual Study Completion Date : August 2008

Resource links provided by the National Library of Medicine





Biospecimen Retention:   Samples Without DNA
Both DNA samples as well as plasma, serum and urine samples were collected from the DCCT/EDIC cohort.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with type 1 diabetes enrolled in the DCCT/EDIC cohort who agreed to participate in our sub-study were enrolled
Criteria
No eligibility criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005474


Sponsors and Collaborators
Medical University of South Carolina
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Maria Lopes-Virella Medical University of South Carolina

Publications:

Responsible Party: Medical University of South Carolina
ClinicalTrials.gov Identifier: NCT00005474     History of Changes
Other Study ID Numbers: 4958
P01HL055782-10 ( U.S. NIH Grant/Contract )
First Posted: May 26, 2000    Key Record Dates
Last Update Posted: April 14, 2015
Last Verified: August 2008

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Autoimmune Diseases
Immune System Diseases